Endoscopic interventions in Barrett's esophagus: Do the dollars make sense?
Advances in the development of endoscopic therapies for Barrett's esophagus have resulted in the emergence of an important paradigm shift for management of early neoplasia and represent an opportunity to alter the natural history of the disease. Clinical incorporation of these endoscopic modalities may have significant implications for disease management and health care delivery from a cost perspective. This article reviews the current literature on the cost analyses of commonly used Barrett endoscopic interventions and summarizes the overall cost-effectiveness of these treatments as compared with surveillance or surgery.
Section of Gastroenterology, Department of Medicine, Center for Endoscopic Research and Therapeutics, The University of Chicago Medical Center, 5758 South Maryland Avenue, MC 9028, Chicago, IL 60637, USA. jchennat@medicine.bsd.uchicago.edu
Jennifer
J
Chennat
Mark K
MK
Ferguson
D001471:Barrett Esophagus / Q000191:economics* / Q000628:therapy*; D004945:Esophagoscopy / Q000191:economics* / Q000379:methods; D006801:Humans; D011230:Precancerous Conditions / Q000191:economics* / Q000628:therapy*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years